Skip to main content
. 2020 Dec 1;13:12367–12382. doi: 10.2147/OTT.S287944

Figure 1.

Figure 1

Mutational landscape of MPN. Results from a target next-generation sequencing analyses in patients with polycythemia vera, essential thrombocythemia, primary myelofibrosis and blast-phase MPN. The graphs show the proportion of patients for each corresponding mutation (both driver JAK2, CALR and MPL mutations and additional somatic mutations). Data from Tefferi et al54,60 and Lasho et al.108